Yingke Private Equity

Founder Qian Mingfei leads the firm and is recognized by industry rankings as a central investment figure. The firm describes itself as research-driven and institutional, indicating a structured internal investment committee even as Qian maintains a visible public role as the primary decision-maker.

Yingke's strategy focuses on anchoring around supply-chain 'entry points' and 'platform companies' within its three core sectors. The firm publicly emphasizes its 'Golden Sycamore' industrial landing initiative and deep government-guided capital relationships, which provide access to strategic sectors where foreign and purely financial investors may face higher barriers to entry.

Yingke operates with a dual structure: a traditional private equity fund management business that deploys institutional capital, alongside a technology industry group entity. The firm's website also references a 'Golden Sycamore' industrial landing program, suggesting operating capabilities designed to integrate portfolio companies with local government development goals.

Yingke covers a wide range of stages from early venture rounds through to pre-IPO positions. Its portfolio includes companies at the seed and start-up stages, as well as growth-stage firms preparing for public listing. The firm's concentration in life sciences and semiconductor hardware, where capital-intensive scale-ups require multiple funding rounds, incentivizes this full-spectrum stage coverage.

Yingke concentrates on three areas: life sciences (including biologics, cancer therapeutics, gene diagnostics, and medical devices), dual-carbon technology (new energy vehicles, photovoltaics, wind power, energy storage, and hydrogen), and hard-core technology (semiconductors, integrated circuits, advanced materials, and high-end manufacturing). The firm claims over 300 portfolio companies across these sectors.

Yingke states that 90% of its capital under management comes from institutional investors, a structure that aligns it more closely with large Chinese insurance companies and state-affiliated allocators than with high-net-worth individuals or family capital. This institutional base shapes the firm's risk appetite and its preference for policy-aligned strategic sectors.

No philanthropic or foundation structure is disclosed on the firm's website. Yingke's public communication focuses entirely on financial returns for institutional limited partners and the industrial development impact of its investments, with no mention of charitable programs or a corporate social responsibility entity.